pharmacy all semester notes and study material previous year qus
Open in Telegram
B PHARMACY previous year qus paper NOTES , BooKs ( B/D PHARMACY) š¢ Search the name of file and you got it in channel #pharmacynotes #PharmaD #medical #Pharmacist #Dpharmacy š JOIN US AND SUPPORT
Show more5 827
Subscribers
-324 hours
-67 days
-1730 days
Data loading in progress...
Similar Channels
Tags Cloud
Incoming and Outgoing Mentions
---
---
---
---
---
---
Attracting Subscribers
August '26
August '26
+58
in 0 channels
July '26
+78
in 0 channels
Get PRO
June '26
+88
in 0 channels
Get PRO
May '26
+88
in 0 channels
Get PRO
April '26
+77
in 0 channels
Get PRO
March '26
+39
in 0 channels
Get PRO
February '26
+40
in 0 channels
Get PRO
January '26
+69
in 0 channels
Get PRO
December '25
+69
in 0 channels
Get PRO
November '25
+65
in 0 channels
Get PRO
October '25
+65
in 0 channels
Get PRO
September '25
+119
in 0 channels
Get PRO
August '25
+96
in 0 channels
Get PRO
July '25
+117
in 0 channels
Get PRO
June '25
+111
in 0 channels
Get PRO
May '25
+65
in 0 channels
Get PRO
April '25
+60
in 0 channels
Get PRO
March '25
+65
in 0 channels
Get PRO
February '25
+49
in 0 channels
Get PRO
January '25
+100
in 0 channels
Get PRO
December '24
+164
in 0 channels
Get PRO
November '24
+192
in 0 channels
Get PRO
October '24
+245
in 0 channels
Get PRO
September '24
+241
in 1 channels
Get PRO
August '24
+287
in 1 channels
Get PRO
July '24
+663
in 0 channels
Get PRO
June '24
+797
in 0 channels
Get PRO
May '24
+923
in 0 channels
Get PRO
April '24
+816
in 0 channels
Get PRO
March '24
+855
in 0 channels
Get PRO
February '24
+735
in 0 channels
Get PRO
January '240
in 0 channels
Get PRO
December '23
+59
in 0 channels
Get PRO
November '23
+746
in 0 channels
| Date | Subscriber Growth | Mentions | Channels | |
| 26 August | +4 | |||
| 25 August | +1 | |||
| 24 August | +2 | |||
| 23 August | +1 | |||
| 22 August | +1 | |||
| 21 August | 0 | |||
| 20 August | +6 | |||
| 19 August | +3 | |||
| 18 August | +7 | |||
| 17 August | +3 | |||
| 16 August | 0 | |||
| 15 August | +1 | |||
| 14 August | +2 | |||
| 13 August | +2 | |||
| 12 August | +3 | |||
| 11 August | +2 | |||
| 10 August | +5 | |||
| 09 August | +1 | |||
| 08 August | +2 | |||
| 07 August | 0 | |||
| 06 August | +4 | |||
| 05 August | +1 | |||
| 04 August | +3 | |||
| 03 August | 0 | |||
| 02 August | 0 | |||
| 01 August | +4 |
Channel Posts
| 2 | Anyone from lonavala?? DM ME | 886 |
| 3 | š§ Clinical Overview of Selected Psychoactive Substances
1. Heroin (Diacetylmorphine)
Class: Semi-synthetic opioid, rapidly metabolized to morphine.
āļøMechanism: μ-opioid receptor agonist ā strong analgesia, euphoria, respiratory depression.
Clinical Concerns:
Rapid CNS penetration ā intense addiction potential.
Overdose: respiratory depression, pinpoint pupils, coma (āopioid triadā).
Withdrawal: agitation, mydriasis, rhinorrhea, diarrhea, muscle cramps.
šAntidote: Naloxone (IV/IM/IN) for acute overdose.
Long-term Risks: HIV, HCV (injection use), collapsed veins, endocarditis.
2. Mephedrone (4-methylmethcathinone, "Meow Meow")
Class: Synthetic cathinone, stimulant (ābath saltsā).
āļøMechanism: Increases synaptic dopamine, norepinephrine, serotonin (reuptake inhibition + release).
Clinical Concerns:
Acute: euphoria, hyperstimulation, increased sociability.
Toxicity: tachycardia, hypertension, agitation, paranoia, seizures, hyperthermia.
Chronic: neurotoxicity, dependence, psychiatric disorders.
šNo specific antidote ā manage supportively (benzodiazepines for agitation/seizures, cooling for hyperthermia).
3. Cocaine
Class: Stimulant, local anesthetic.
āļøMechanism: Blocks reuptake of dopamine, norepinephrine, serotonin.
Clinical Concerns:
Acute: intense euphoria, tachycardia, hypertension, mydriasis.
Complications: myocardial infarction (coronary vasospasm), stroke, seizures, sudden death.
Chronic: septal perforation (snorting), psychiatric effects, strong addiction potential.
šTreatment of Toxicity: Benzodiazepines (for agitation, hypertension), avoid β-blockers (unopposed α-effect).
4. Caffeine
Class: Methylxanthine stimulant.
āļøMechanism: Adenosine receptor antagonist ā ā CNS stimulation, ā catecholamines.
Clinical Concerns:
Moderate dose: alertness, reduced fatigue.
High dose: anxiety, tachycardia, insomnia, GI upset.
Toxic dose (>1 g): arrhythmias, seizures.
Withdrawal: Headache, irritability, fatigue.
5. Dopamine (DA)
Class: Endogenous catecholamine.
āļøMechanism (dose-dependent):
Low dose: D1 receptor ā renal vasodilation.
Moderate dose: β1 receptor ā ā cardiac contractility.
High dose: α1 receptor ā vasoconstriction.
šClinical Use: Cardiogenic/septic shock (IV infusion).
Adverse Effects: Tachyarrhythmias, extravasation necrosis (treat with phentolamine).
6. Opioids (general, incl. Morphine, Codeine, Fentanyl)
Class: μ-opioid receptor agonists.
Effects: Analgesia, sedation, respiratory depression, constipation, euphoria.
Clinical Concerns:
Overdose ā respiratory arrest.
Dependence & tolerance common.
šAntidote: Naloxone (short-acting), Naltrexone (maintenance).
Clinical Uses: Pain, anesthesia, palliative care, cough, diarrhea.
7. Adrenaline (Epinephrine)
Class: Endogenous catecholamine, adrenergic agonist.
āļøMechanism:
α1 ā vasoconstriction, ā BP.
β1 ā ā HR, ā contractility.
β2 ā bronchodilation.
ā
ļøClinical Uses:
Anaphylaxis (IM first-line).
Cardiac arrest (IV/IO).
Added to local anesthetics (vasoconstriction).
Adverse Effects: Tachyarrhythmias, hypertension, anxiety, tremor.
š Key Clinical Pearls
Heroin & opioids: respiratory depression is the killer ā always think naloxone.
Mephedrone & cocaine: sympathetic storm ā benzodiazepines are first-line.
Caffeine: mild compared to others, but toxicity at high doses.
Dopamine & adrenaline: dose-dependent receptor activity ā lifesaving in shock/anaphylaxis.
š References
Pharmacotherapy Principles and Practice, 6th Edition
American College of Clinical Pharmacy (ACCP) ā Toxicology & Critical Care
UpToDate (Opioid toxicity, Cocaine, Synthetic cathinones, Caffeine, Dopamine in shock, Epinephrine)
Lexicomp (Lexi-Drugs Online)
Goodman & Gilmanās The Pharmacological Basis of Therapeutics, 13th Edition | 1 207 |
| 4 | No text... | 900 |
| 5 | No text... | 861 |
| 6 | No text... | 788 |
| 7 | No text... | 591 |
| 8 | No text... | 633 |
| 9 | No text... | 575 |
| 10 | No text... | 497 |
| 11 | No text... | 551 |
| 12 | No text... | 598 |
| 13 | https://youtu.be/namhmWyy0IE | 143 |
| 14 | https://youtu.be/aYUg06rA5-U | 305 |
| 15 | https://t.me/KnowldgeHubCtet
Join our new teligram channel | 869 |
| 16 | https://youtube.com/shorts/cFhfGKdIyWg?si=pxIbLt9cbUlOCv5_ | 355 |
| 17 | Like subscribe and share | 812 |
| 18 | https://youtu.be/hZGb_3sal-Q?si=C2ljwMQJePgHI34z | 376 |
| 19 | https://a.co/d/0hvaXjzj | 1 076 |
| 20 | Buy this product from Amazon.com | 1 120 |
